Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Roberto Burioni is active.

Publication


Featured researches published by Roberto Burioni.


Research in Virology | 1997

Human monoclonal recombinant Fabs specific for HCV antigens obtained by repertoire cloning in phage display combinatorial vectors

P. Plaisant; Roberto Burioni; A. Manzin; L. Solforosi; M. Candela; A. Gabrielli; Giovanni Fadda; Massimo Clementi

Molecular cloning of the antibody repertoire in phage display combinatorial vectors is a powerful method enabling the dissection of the immunoresponse against a given pathogen. In this paper we describe the construction of a combinatorial library displayed on phage surface, containing the antibody repertoire of a patient with high serological response against hepatitis C virus (HCV) antigens. Following selection of the library against solid-phase-bound antigen, sixteen human antibody Fab fragments able to bind to HCV-specific antigens were generated and studied for binding characteristics. The majority of them appeared to have specificity for the HCV c33 peptide. All the clones reacting with the c33 peptide shared the same heavy-chain CDR3 sequence. This is the first report of molecular cloning in a combinatorial phage display vector of the antibody repertoire of an anti-HCV-positive patient.


Journal of Immunological Methods | 1998

A vector for the expression of recombinant monoclonal Fab fragments in bacteria

Roberto Burioni; P. Plaisant; Francesca Bugli; Valeria Delli Carri; Massimo Clementi; Giovanni Fadda

The availability of genes coding for monoclonal Fab fragments of a desired specificity permits their expression in bacteria and provides a simple method for the generation of good quality reagents. In this paper we describe a new phagemid vector for the production of recombinant Fabs from genes obtained from phage display combinatorial libraries. The phagemid features an antibiotic resistance cassette which, once inserted between the heavy chain fragment and the light chain genes, avoids unwanted recombination and preserves useful restriction sites not affecting the Fab production rate.


Research in Virology | 1998

A new subtraction technique for molecular cloning of rare antiviral antibody specificities from phage display libraries

Roberto Burioni; P. Plaisant; Francesca Bugli; Laura Solforosi; V. Delli Carri; Pietro E. Varaldo; Giovanni Fadda

The preparation of random combinatorial libraries exposed on the surface of phage provides a route for the selection of diverse high affinity human monoclonal antibodies. However, in particular settings, the isolation of genes coding for a rare antibody can be elusive because some epitopes are predominant and because, in the case of impure antigens, the protein or any compound of interest can be present in relatively minimal amount. In this paper, we describe the successful utilization of a new strategy of preadsorption panning that allowed us to clone a rare human monoclonal antibody fragment and to access a different antibody repertoire. The procedure is easy, fast, inexpensive, can be used together with other panning techniques and can be particularly useful in cloning antibodies against rare or unknown determinants.


Research in Virology | 1997

An improved phage display vector for antibody repertoire cloning by construction of combinatorial libraries.

Roberto Burioni; P. Plaisant; V. Delli Carri; A. Vannini; Teresa Spanu; Massimo Clementi; Giovanni Fadda; Pietro E. Varaldo

Phagemid pComb3 is a widely used vector for molecular cloning of the antibody repertoire and for production of phage display libraries. However, in practical use, the utilization of this vector has some drawbacks. In this work we describe the construction of pComb3/TIG, an improved, easily manipulated vector for the cloning and display of antibody fragment libraries on the surface of filamentous phage. The two small stuffer fragments at the cloning sites were replaced with long DNA fragments, for easier differentiation of the correctly cut forms of the vector. Moreover, in pComb3/TIG the fragment at the heavy-chain-fragment cloning site contains an acid phosphatase-encoding gene. This feature allows the easy distinction of the Escherichia coli cells containing the unmodified form of the phagemid instead of the heavy-chain fragment coding cDNA in a simple plate histochemical assay.


Research in Virology | 1998

Probing the natural antibody repertoire by combinatorial cloning of IgM and IgD isotypes in phage display vectors

Roberto Burioni; P. Plaisant; Francesca Bugli; V. Delli Carri; M. Candela; A. Gabrielli; Giovanni Fadda

It is well known that immunoglobulins with no identifiable immunogenic origin, called natural antibodies, are present in the sera of healthy individuals and their role as a defence against important pathogens has been proposed. Unfortunately, the studies are hampered by the fact that these immunoglobulins seem to have low affinity and to be polyreactive, and are commonly available in polyclonal preparations. Lately, new technologies for the production of monoclonal antibodies became available, and in particular the cloning of genes coding for antibody fragments in combinatorial phage display vectors provided a handy tool for the selection of human monoclonal antibodies. In this work, we describe the successful development of a technology for the molecular cloning of combinatorial phage display libraries containing genes coding exclusively for antibody fragment of the IgM or IgD phenotype. These libraries can be useful for molecular cloning of monoclonal antibodies of the IgM and IgD phenotype and can help elucidate the role played by natural antibodies in defence against infectious agents.


Hepatology | 1998

Dissection of human humoral immune response against hepatitis C virus E2 glycoprotein by repertoire cloning and generation of recombinant fab fragments

Roberto Burioni; P. Plaisant; Aldo Manzin; Domenico Rosa; Valeria Delli Carri; Francesca Bugli; Laura Solforosi; Sergio Abrignani; Pietro E. Varaldo; Giovanni Fadda; Massimo Clementi


Archive | 2008

Method For The Preparation Of New Oligoclonal Antibodies

Massimo Clementi; Roberto Burioni


Archive | 2006

Novel phage display technologies

Roberto Burioni; Massimo Clementi


Archive | 2002

Human recombinant antibody against the hepatitis c (hcv) non structural ns3 protein nucleic acid and uses thereof

Roberto Burioni; Massimo Clementi


Archive | 2008

The use of a human monoclonal anti-hcv antibody as a medicament for the therapeutic treatment and prevention of hcv infections

Roberto Burioni; Massimo Clementi

Collaboration


Dive into the Roberto Burioni's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Giovanni Fadda

Catholic University of the Sacred Heart

View shared research outputs
Top Co-Authors

Avatar

P. Plaisant

Catholic University of the Sacred Heart

View shared research outputs
Top Co-Authors

Avatar

Francesca Bugli

Catholic University of the Sacred Heart

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

V. Delli Carri

Catholic University of the Sacred Heart

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Nicasio Mancini

Catholic University of the Sacred Heart

View shared research outputs
Top Co-Authors

Avatar

Valeria Delli Carri

Catholic University of the Sacred Heart

View shared research outputs
Top Co-Authors

Avatar

Laura Solforosi

Scripps Research Institute

View shared research outputs
Researchain Logo
Decentralizing Knowledge